| Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial SP Buchbinder, DV Mehrotra, A Duerr, DW Fitzgerald, R Mogg, D Li, ... The Lancet 372 (9653), 1881-1893, 2008 | 2022 | 2008 |
| Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women L Ahdieh, RS Klein, R Burk, S Cu-Uvin, P Schuman, A Duerr, M Safaeian, ... The Journal of infectious diseases 184 (6), 682-690, 2001 | 442 | 2001 |
| The outer boundary of the cytoskeleton: a lamina derived from plasma membrane proteins A Ben-Ze'ev, A Duerr, F Solomon, S Penman Cell 17 (4), 859-865, 1979 | 350 | 1979 |
| Bacterial vaginosis and HIV seroprevalence among female commercial sex workers in Chiang Mai, Thailand CR Cohen, A Duerr, N Pruithithada, S Rugpao, P Garcia, K Nelson, ... Aids 9 (9), 1093-1098, 1995 | 345 | 1995 |
| Extended follow-up confirms early vaccine-enhanced risk of HIV acquisition and demonstrates waning effect over time among participants in a randomized trial of recombinant … A Duerr, Y Huang, S Buchbinder, RW Coombs, J Sanchez, C del Rio, ... The Journal of infectious diseases 206 (2), 258-266, 2012 | 286 | 2012 |
| Step Study Protocol Team. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial SP Buchbinder, DV Mehrotra, A Duerr, DW Fitzgerald, R Mogg, D Li, ... Lancet 372 (9653), 1881-1893, 2008 | 283 | 2008 |
| Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women HD Strickler, JM Palefsky, KV Shah, K Anastos, RS Klein, H Minkoff, ... Journal of the National Cancer Institute 95 (14), 1062-1071, 2003 | 265 | 2003 |
| Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial M Rolland, S Tovanabutra, AC Decamp, N Frahm, PB Gilbert, ... Nature medicine 17 (3), 366-371, 2011 | 260 | 2011 |
| Overview of STEP and Phambili trial results: two phase IIb test-of-concept studies investigating the efficacy of MRK adenovirus type 5 gag/pol/nef subtype B HIV vaccine G Gray, S Buchbinder, A Duerr Current opinion in HIV and AIDS 5 (5), 357-361, 2010 | 226 | 2010 |
| Male viral load and heterosexual transmission of HIV-1 subtype E in northern Thailand S Tovanabutra, V Robison, J Wongtrakul, S Sennum, V Suriyanon, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 29 (3), 275-283, 2002 | 218 | 2002 |
| Longitudinal study of cervical squamous intraepithelial lesions in human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women P Schuman, SE Ohmit, RS Klein, A Duerr, S Cu-Uvin, DJ Jamieson, ... The Journal of infectious diseases 188 (1), 128-136, 2003 | 195 | 2003 |
| Merck Ad5/HIV induces broad innate immune activation that predicts CD8+ T-cell responses but is attenuated by preexisting Ad5 immunity DE Zak, E Andersen-Nissen, ER Peterson, A Sato, MK Hamilton, ... Proceedings of the National Academy of Sciences 109 (50), E3503-E3512, 2012 | 188 | 2012 |
| Complications of interval laparoscopic tubal sterilization: findings from the United States Collaborative Review of Sterilization DJ Jamieson, SD Hillis, A Duerr, PA Marchbanks, C Costello, ... Obstetrics & Gynecology 96 (6), 997-1002, 2000 | 181 | 2000 |
| Human adenovirus-specific T cells modulate HIV-specific T cell responses to an Ad5-vectored HIV-1 vaccine N Frahm, AC DeCamp, DP Friedrich, DK Carter, OD Defawe, JG Kublin, ... The Journal of clinical investigation 122 (1), 359-367, 2012 | 167 | 2012 |
| Incident and persistent vulvovaginal candidiasis among human immunodeficiency virus–infected women: Risk factors and severity A Duerr, CM Heilig, SF Meikle, S Cu-Uvin, RS Klein, A Rompalo, ... Obstetrics & Gynecology 101 (3), 548-556, 2003 | 158 | 2003 |
| Longitudinal analysis of bacterial vaginosis: findings from the HIV epidemiology research study DJ Jamieson, A Duerr, RS Klein, P Paramsothy, W Brown, S Cu-Uvin, ... Obstetrics & Gynecology 98 (4), 656-663, 2001 | 158 | 2001 |
| Changes in sexual behavior and STI diagnoses among MSM initiating PrEP in a clinic setting MA Montaño, JC Dombrowski, S Dasgupta, MR Golden, A Duerr, ... AIDS and Behavior 23, 548-555, 2019 | 155 | 2019 |
| Treatment options for vulvovaginal candidiasis, 1993 SE Reef, WC Levine, MM McNeil, S Fisher-Hoch, SD Holmberg, A Duerr, ... Clinical Infectious Diseases 20 (Supplement_1), S80-S90, 1995 | 148 | 1995 |
| Characterization of genital human papillomavirus infection in women who have or who are at risk of having HIV infection DJ Jamieson, A Duerr, R Burk, RS Klein, P Paramsothy, P Schuman, ... American journal of obstetrics and gynecology 186 (1), 21-27, 2002 | 146 | 2002 |
| HIV vaccines: new frontiers in vaccine development A Duerr, JN Wasserheit, L Corey Clinical Infectious Diseases 43 (4), 500-511, 2006 | 144 | 2006 |
